Bipolar II Disorder clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 30-65
The purpose of this study is to determine the safety, tolerability, and feasibility of psilocybin therapy in people with Bipolar II Disorder.
San Francisco, California
Our lead scientists for Bipolar II Disorder research studies include Joshua D Woolley, MD,PhD.